text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "T cells"
Too many choices? Use the filter option on the left to narrow your product listing.
31-40 of 994 results
  • P3 Primary Cell 4D-Nucleofector<sup class=reg>®</sup> X Kit L
    Compare
    P3 Primary Cell 4D-Nucleofector® X Kit L
    Catalog #: V4XP-3024

    For efficient transfection of specific primary cells, e.g. human T cells, CD34 or rat neurons, in the 4D-NucleofectorTM X Unit (100 µL format).

     

    Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.

    Sales unit: kit
    SA
  • TheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell Medium
    Compare
    TheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell Medium
    Catalog #: BE08-879H
    TheraPEAK™X-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 5L bag
    Sales unit: each
    EA
  • Fresh Human Leukopak - Neupogen(R) Mobilized (Day 6 Collection, Full Bag)
    Compare
    Fresh Human Leukopak - Neupogen(R) Mobilized (Day 6 Collection, Full Bag)
    Catalog #: 3Y-300B
    Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 mcg/kg/day x 5 days, Second Collection, Day 6, 1 Bag
    Sales unit: each
    EA
  • Fresh Human Leukopak - Neupogen® Mobilized (Day 5 Collection, Full Bag)
    Compare
    Fresh Human Leukopak - Neupogen® Mobilized (Day 5 Collection, Full Bag)
    Catalog #: 3Y-300
    Fresh human leukopheresis product collected from peripheral blood mobilized with Neupogen(R) 10 mcg/kg/day x 5 days, 1 Bag, Day 5 Collection
    Sales unit: each
    EA
  • TheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell Medium
    Compare
    TheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell Medium
    Catalog #: BEBP02-061Q

    TheraPEAKTMX-VIVOTM 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L

    Sales unit: each
    EA
  • NHDC - Human Dendritic Cells, 2.5 Million
    Compare
    NHDC - Human Dendritic Cells, 2.5 Million
    Catalog #: CC-2701

    Cryopreserved ampule of Normal Human Dendritic Cells (NHDC) containing ≥2.5 million cells

    Sales unit: each
    EA
  • Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million
    Compare
    Human Peripheral Blood Mononuclear Cells (hPBMC), Cryopreserved, 50 million
    Catalog #: CC-2702
    Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells
    Sales unit: each
    EA
  • 4D-Nucleofector<sup class=reg>®</sup> LV Unit
    Compare
    4D-Nucleofector® LV Unit
    Catalog #: AAF-1002L

    For closed, scalable large-scale transfection of up to 1x109 cells.

    Sales unit: items
    ST
  • TheraPEAK<sup class=reg>®</sup> LV Nucleocuvette<sup class=reg>®</sup> Cartridge, weldable (5 pcs)
    Compare
    TheraPEAK® LV Nucleocuvette® Cartridge, weldable (5 pcs)
    Catalog #: G4LN-7520W

    For use in combination with TheraPEAK® Nucleofector® Solution Sets, supporting the use of the 4D-Nucleofector®  LV Unit in a GMP environment.

    Sales unit: items
    ST
  • TheraPEAK<sup class=reg>®</sup> 4D-Nucleofector<sup class=reg>®</sup> LV Reservoirs, weldable (5 pcs)
    Compare
    TheraPEAK® 4D-Nucleofector® LV Reservoirs, weldable (5 pcs)
    Catalog #: G4LR-1501W
    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
    Sales unit: items
    ST
1-10 of 1500 results
  • Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell Generation
    Poster on inducible Cas9 T Cells
  • Synthego_Lonza_Protocol_Genome Editing of Resting T cells
    Technical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • PBMC Based T Cell Proliferation Assay
    Protocol instructions
  • Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T Cells
    Instructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
  • Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCs
    Protocol for DC and T Cell Assay from Matched PBMCs
  • Case Study – Improving the Expansion of Patients' T Cells
    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
  • cGMP Kit T Optimization Protocol - Nucleofector™ 1/2 Device Series
    cGMP Cell Line Nucleofector Kit T
  • Synthego-Lonza Genome Editing of Resting T cells
    Case Study on Genome Editing of Resting T cells
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.